---
title: "Standard Wellness partners with DABSTRACT to expand concentrate offerings in Missouri. Date: Feb. 5, 2026. Leading cannabis company."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275014634.md"
description: "In Missouri on February 5, 2026, Standard Wellness Holdings, LLC revealed a strategic collaboration with the renowned concentrate brand DABSTRACT, a subsidiary of UGC Inc. This partnership aims to introduce the terpene-rich products of DABSTRACT to a wider market. Standard Wellness stands as a prominent player in the cannabis industry, emphasizing vertical integration. The move signifies a significant alliance in the sector, underlining the growing importance of terpene-focused offerings."
datetime: "2026-02-05T17:45:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275014634.md)
  - [en](https://longbridge.com/en/news/275014634.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275014634.md)
---

# Standard Wellness partners with DABSTRACT to expand concentrate offerings in Missouri. Date: Feb. 5, 2026. Leading cannabis company.

In Missouri on February 5, 2026, Standard Wellness Holdings, LLC revealed a strategic collaboration with the renowned concentrate brand DABSTRACT, a subsidiary of UGC Inc. This partnership aims to introduce the terpene-rich products of DABSTRACT to a wider market. Standard Wellness stands as a prominent player in the cannabis industry, emphasizing vertical integration. The move signifies a significant alliance in the sector, underlining the growing importance of terpene-focused offerings.

### Related Stocks

- [AYRWF.US](https://longbridge.com/en/quote/AYRWF.US.md)

## Related News & Research

- [NewLake Capital Q4 revenue beats estimates](https://longbridge.com/en/news/277997508.md)
- [11:45 ET
			
			
				Empowered Mind & Wellness Brings Next-Generation Technology to Optimize Mental Health](https://longbridge.com/en/news/274541849.md)
- [HighTower Advisors LLC Raises Holdings in Moelis & Company $MC](https://longbridge.com/en/news/287037150.md)